(0695–0723) Epidemiology and Public Health Poster I

Sunday, November 13, 2022

9:00 AM – 10:30 AM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

9:00 AM – 10:30 AM Eastern Time

Epidemiology of Behçet’s Disease in Northern Spain
Abstract Poster Presenter: Carmen Alvarez Reguera, MD – Hospital Universitario MarquÃ©s de Valdecilla
9:00 AM – 10:30 AM Eastern Time

WITHDRAWN
9:00 AM – 10:30 AM Eastern Time

Are Fibromyalgia and Depression as Common as Any Primary Diagnosis in Routine Rheumatology Care, Albeit as Secondary Diagnoses, but Which May Confound Clinical Assessment?
Abstract Poster Presenter: Theodore Pincus, MD – Rush University Medical Center
9:00 AM – 10:30 AM Eastern Time

Cohort Study of Cigarette Smoking and the Risk of Developing Polymyalgia Rheumatica Among Women
Abstract Poster Presenter: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
9:00 AM – 10:30 AM Eastern Time

Effectiveness by Disease Severity in Patients with Psoriatic Arthritis Treated with Apremilast in the CorEvitas Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
Abstract Poster Presenter: Alexis Ogdie, MD – University of Pennsylvania
9:00 AM – 10:30 AM Eastern Time

Accurate Identification of ANCA-Associated Vasculitis Cases from Clinical Notes Using Machine Learning
Abstract Poster Presenter: Zachary Wallace, MD, MSc – Massachusetts General Hospital
9:00 AM – 10:30 AM Eastern Time

Reduced Humoral but Maintained Cellular Immune Response to a 3^rd COVID-19 Vaccination in Patients with Immune-Mediated Inflammatory Diseases as Compared to Healthy Controls over a 3-months Observational Period
Abstract Poster Presenter: Daniel Mrak, MD – Medical University of Vienna
9:00 AM – 10:30 AM Eastern Time

Fourth SARS-CoV-2 Vaccine Dose in Rituximab Treated Patients: An Open Label Extension Study
Abstract Poster Presenter: Daniel Mrak, MD – Medical University of Vienna
9:00 AM – 10:30 AM Eastern Time

Vaccination Against SARS-CoV2 in Patients with Systemic Autoimmune Diseases: A Safety Report from EULAR COVAX Registry
Abstract Poster Presenter: Jose A. Gomez-Puerta, MD, PhD, MPH – Hospital Clínic
9:00 AM – 10:30 AM Eastern Time

Clinically Suspect Arthralgia Patients with a Low Educational Attainment Have an Increased Risk to Develop Inflammatory Arthritis
Abstract Poster Presenter: Sarah Khidir, MD, MA – Leiden University Medical Center
9:00 AM – 10:30 AM Eastern Time

Severity of SARS-CoV-2 Omicron Breakthrough Infections in Patients with Rheumatic Immune-mediated Inflammatory Diseases and Healthy Controls: Data from a Prospective Cohort Study
Abstract Poster Presenter: Laura Boekel, BSc – Vrije Universiteit Amsterdam
9:00 AM – 10:30 AM Eastern Time

Association Between Metabolic Syndrome and Knee Pain over 10-13 Years in Middle-Aged Adults
Abstract Poster Presenter: Ambrish Singh, PhD – UTAS
9:00 AM – 10:30 AM Eastern Time

Accuracy of Administrative Claims Prescription Fill Data to Estimate Glucocorticoid Use and Dose in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Rachel Galvao, MD – Yale New Haven Hospital
9:00 AM – 10:30 AM Eastern Time

The Impact of Early Antimalarial Adherence on Future Acute Care Utilization Among Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients: A Population-based Study
Abstract Poster Presenter: Md Rashedul Hoque, BSc, MSc – Faculty of Health Sciences, Simon Fraser University
9:00 AM – 10:30 AM Eastern Time

Population Based Prevalence and Incidence of Mixed Connective Tissue Disease from the Manhattan Lupus Surveillance Program
Abstract Poster Presenter: Ghadeer Hasan, MD, MPH – Optum
9:00 AM – 10:30 AM Eastern Time

Risk Factors Associated with COVID-19 Breakthrough Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Cohort Study
Abstract Poster Presenter: Naomi Patel, MD – Massachusetts General Hospital
9:00 AM – 10:30 AM Eastern Time

Improvement in Excess Mortality in Patients with Rheumatoid Arthritis over the Last Two Decades: A Danish Population-based Matched Cohort Study
Abstract Poster Presenter: Bolette Soussi, MD – Center of Rheumatic Research Aalborg, Department of Rheumatology, Aalborg University Hospital
9:00 AM – 10:30 AM Eastern Time

Disease Prevalence and Patient Characteristics in Patients with and Without Scleroderma Renal Crisis - A National US-based Inpatient Comparison Study
Abstract Poster Presenter: Anila Hussain, MD – Temple University Hospital
9:00 AM – 10:30 AM Eastern Time

The Epidemiology, Clinical Outcomes, and Healthcare Resource Utilization of IgG4-Related Disease Among Commercially Insured People in the United States
Abstract Poster Presenter: Zachary Wallace, MD, MSc – Massachusetts General Hospital
9:00 AM – 10:30 AM Eastern Time

Real-World Treatment Effectiveness of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Yinzhu Jin, MS – Brigham and Women's Hospital
9:00 AM – 10:30 AM Eastern Time

Safety and Immunogenicity of Mixed COVID19 Vaccine Regimens in Immune-mediated Inflammatory Diseases: An Observational Cohort
Abstract Poster Presenter: Carol Hitchon, MD, MSc – University of Manitoba
9:00 AM – 10:30 AM Eastern Time

Posttraumatic Stress Disorder Symptoms in Systemic Autoimmune Rheumatic Disease Patients During the Early COVID-19 Pandemic
Abstract Poster Presenter: Jack Ellrodt, BA – Williams College
9:00 AM – 10:30 AM Eastern Time

Treatment Utilization in Dermatomyositis: An Analysis of Electronic Medical Records in the United States
Abstract Poster Presenter: Adrian Kielhorn, MBA – Alexion
9:00 AM – 10:30 AM Eastern Time

Biomarkers Predict Worsening of Lumbar Spine Degeneration and Low Back Pain: The Johnston County Osteoarthritis Project
Abstract Poster Presenter: Kenneth Taylor, PhD, PT, DPT – Duke University School of Medicine
9:00 AM – 10:30 AM Eastern Time

Effect of Patient-reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice
Abstract Poster Presenter: Stefan Weiss, MD, MBA, MHS – OM1
9:00 AM – 10:30 AM Eastern Time

Risk-Benefit Assessment of Primary Prophylaxis for Pneumocystis Pneumonia in Patents with Rheumatic Diseases Exposed to Rituximab: A Multicenter Cohort Study
Abstract Poster Presenter: Jun Won Park, MD – Seoul National University Hospital
9:00 AM – 10:30 AM Eastern Time

Inflammatory Rheumatic Disease and the Risk of Death Related to Coronavirus Disease-19 (COVID-19): An Analysis of the UK Biobank with Stratification by Sex
Abstract Poster Presenter: Ashley Archer, BS – UAB Heersink School of Medicine
9:00 AM – 10:30 AM Eastern Time

Cardiovascular and Oncologic Outocomes of Anti-TNF Alfa and JAK Inhibitors in Patients with Rheumatoid and Psoriatic Arthritis. Real World Data and Insights of BIOBADASAR 3.0 Registry
Abstract Poster Presenter: Alejandro Brigante, Sr., MD – Sanatorio Güemes - UNISAR
9:00 AM – 10:30 AM Eastern Time

Risk of Major Adverse Cardiovascular and Venous Thromboembolism Events in Patients with Rheumatoid Arthritis Exposed to JAK Inhibitors versus Adalimumab: A Nationwide Cohort Study
Abstract Poster Presenter: Lea Hoisnard, MD – Université Paris Est Créteil